Program Sponsors: ColoWatch
Session Description: Colorectal cancer rates are rising in those under age 50. A screening test should be both safe and accurate. No patient should experience serious injury or death from any screening test, yet traditional colonoscopy carries a significant risk of both. Virtual Colonoscopy, also known as CT Colonography, is safe, requires no sedation, and is the most accurate screening test available for detecting both colorectal cancer and the precursor polyps that can become colorectal cancer. In this lecture, we will present the case for virtual colonoscopy as the screening test of choice for average-risk patients.
Learning Objectives:
Speaker:
Mark E. Klein, MD, President, ColoWatch
Dr. Klein is Co-Founder of ColoWatch™. Prior to joining ColoWatch™, he practiced as a Board-Certified diagnostic radiologist in the Washington, DC area for over 40 years. He has performed over 8,000 CT Colonography screening studies, the basis of the ColoWatch™ colorectal screening study.
Dr. Klein is Co-Director of the CT Colonography course at the American College of Radiology Education Center where he has taught hundreds of doctors from around the nation and the world how to perform CT Colonography. He is Adjunct Assistant Professor of Radiology at The George Washington University School of Medicine and Health Sciences.
Dr. Klein received his M.D degree from The State University of New York Downstate College of Medicine. He completed his residency and fellowship in Diagnostic Radiology at The George Washington University Hospital. He also holds an MBA from The George Washington University. Dr. Klein is a Fellow of the American College of Radiology.
This webinar is pending CE credit approval!
AHRA Member: Live attendance and recording is free to members
Non-Member: Live attendance only is free to non-members